MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HOLOHAN, P. D.
Right arrow Articles by ROSS, C. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HOLOHAN, P. D.
Right arrow Articles by ROSS, C. R.

Molecular Pharmacology, Vol 16, 343-356, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Reconstitution of N1-Methylnicotinamide and p-Aminohippuric Acid Transport in Phospholipid Vesicles with a Protein Fraction Isolated from Dog Kidney Membranes

PETER D. HOLOHAN 1, NESS I. PESSAH 1, ISAAC N. PESSAH 1, and CHARLES R. ROSS 1

1 Department of Pharmacology, State University of New York, Upstate Medical Center, Syracuse, New York 13210

N1-methylnicotinamide (NMN) and p-aminohippurate (PAH) transport can be reconstituted in phospholipid vesicles by incorporating the solubilized membrane proteins into artificial phospholipid membranes. After solubilization with the non-ionic detergent, Lubrol WX, the protein solution was added to a phospholipid solution (prepared by dissolving the phospholipids in the detergents) and the phospholipid:protein vesicles were allowed to form during dialysis. Transport in these vesicles was studied with radioactively labeled NMN or PAH; the transport for NMN was 173 to 394 pmoles/mg of protein/5 min and for PAH was 263 to 505 pmoles/mg of protein/5 min. Transport into control vesicles (without protein) was less than 10% of these values. The transport of NMN and PAH displayed properties of facilitated diffusion: 1) equilibrium was reached within 5 min; 2) pH dependence (optimum for NMN was 7.4, for PAH, 7.0); 3) protein and lipid concentration dependence; 4) saturability (Km estimated from frac12 saturation was approximately 1 mM for both NMN and PAH); and 5) specificity, in that known competitors of these transport systems inhibited uptake. In addition, it appears as if specific phospholipids are required in that only sphingomyelin and phosphatidylcholine functioned in reconstituting transport. Using reconstitution as the mode of assaying the proteins through an isolation procedure after solubilization, we achieved a 45 fold purification of the NMN and PAH transport proteins. Interestingly, although our data clearly show that the two transport systems are distinct entities, the two activities copurify. Based upon these results, we propose that we have accomplished a partial purification of the "carrier" proteins involved in the renal secretion of organic compounds.

Note:
ACKNOWLEDGMENTS The authors would like to thank Dr. A. R. Bassel for the electron microscopy, Drs. J. D. Robinson and I. M. Weiner for their critical reading of this manuscript and to Dorothy Stechyshyn for typing it.

Submitted on June 1, 1977
Accepted on July 4, 1978







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics